Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge Setup Score
Trend Edge rates AYTU Bullish with a Setup Score of 22, net conviction 18, actionability 27. How the Setup Score works →
Total Setup Score
22
Directional Bias
Bullish
Net Conviction
18
Actionability
27 (in range)
Key signals behind this score
Fresh Trend Turn — 80wk turn 25w
80wk Uptrend — trend only (sma 2.21 vs px 2.03)
Funds Accumulating — momZ +0.53 · 0.40→0.43
Short Squeeze Setup — velZ +0.71 · age 36w×0.89 · 4.35%
Founder-Led — founder/CEO led
About Aytu BioScience Inc
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT A central nervous system stimulant indicated for the treatment of ADH… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Exchange: NASDAQ
IPO Date: February 1, 2017
Headquarters: 7900 East Union Avenue, Denver, CO, United States, 80237
Founder-Led: Yes — Joshua R. Disbrow (Chief Executive Officer)
Key Metrics
Current Price
$2.03
Market Cap
$22.3M
Float
7.7M
Shares Outstanding
10.9M
P/E (Forward)
9.16
Price/Sales (TTM)
0.39
vs. Analyst Target
+376.2% to analyst PT
Profit Margin
-24.76%
Operating Margin (TTM)
-4.82%
Revenue (TTM)
$57.6M
Dividend Rate
None
Analyst Target Price
$9.67 (3 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2021
$65.6M
-$58.3M
$29.2M
-$29.0M
2022
$96.7M
-$109M
$50.3M
-$28.0M
2023
$107M
-$17.1M
$66.6M
-$3.3M
2024
$65.2M
-$15.8M
$49.1M
$1.4M
2025
$66.4M
-$13.6M
$45.8M
-$4.7M
2026
$57.6M
-$14.3M
$36.8M
-$8.3M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Sep 2025
$13.9M
$2.0M
Dec 2025
$15.2M
-$10.6M
Mar 2026
$12.4M
-$5.6M
Jun 2026
$16.1M
-$15,000
Ownership & Float
Insider Ownership
8.2%
Institutional Ownership
35.5%
Short Float
4.3%
% of All Funds Holding
0.43%
Number of Funds Holding
38
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$2.21
Near-term / short-term trend
Weekly
40-Week SMA
$2.36
Medium-term trend
Weekly
80-Week SMA
$2.21
Cyclical trend (business cycle)
Weekly
200-Week SMA
$2.31
Secular trend (multi-year)
Monthly
10-Month SMA
$2.36
Near-term monthly trend
Monthly
20-Month SMA
$2.19
Medium-term monthly trend
Monthly
40-Month SMA
$2.28
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$1.80
support
1.43x
15 months ago
$1.40
support
9.27x
16 months ago
$1.20
support
1.09x
17 months ago
Historical Earnings Reactions (68 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.97%
0.00%
27.94%
43.70%
-13.27%
1 Day
-0.90%
0.00%
16.18%
91.85%
-27.27%
1 Week
-2.75%
-1.11%
14.71%
233.33%
-74.03%
2 Weeks
0.60%
-4.88%
17.65%
250.00%
-75.27%
1 Month
4.86%
-6.45%
29.85%
250.00%
-84.36%
Next earnings: November 12, 2026 (31 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
2.7%
27.8%
18
Feb
-3.4%
16.7%
18
Mar
11.8%
38.9%
18
Apr
9.7%
38.9%
18
May
-14.1%
16.7%
18
Jun
2.4%
22.2%
18
Jul
1.6%
33.3%
18
Aug
47.1%
11.1%
18
Sep
10.6%
27.8%
18
Oct
7.3%
33.3%
18
Nov
-12.7%
5.6%
18
Dec
8.6%
38.9%
18
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
1.01%
24.2%
851
Tuesday
0.43%
25.5%
933
Wednesday
0.44%
23.1%
930
Thursday
0.48%
22.8%
911
Friday
0.36%
26.0%
908
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 35.5%
Insider Transactions — Smart Summary
Total insider ownership: 8.2%
Founder-led management: Joshua R. Disbrow (Chief Executive Officer)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Aytu BioScience Inc
(AYTU) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.